FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway
PLOS ONE · 2025
DOI: 10.1371/journal.pone.0318776 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Longhai Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Cyclin-Dependent Kinase 2, Tumor Suppressor Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bozhou Key R&D projects.
Abstract (Originalsprache)
Objective
Colorectal cancer (CRC) is the third most prevalent malignant tumor type and the second leading cause of cancer-related death. Sequence similarity family 50 member A (FAM50A) plays a vital role in numerous disease processes, including tumor progression. This study aimed to evaluate the prognostic significance of FAM50A in CRC and to explore its role in CRC cell proliferation.
Methods
TCGA and GTEX databases and immunohistochemical staining (IHC) was used to study the expression of FAM50A in CRC tissues. Patient survival data were used to assess the prognostic significance of FAM50A in CRC using Kaplan–Meier analysis and Cox regression analysis. The Cell Counting Kit-8 (CCK-8), 5-ethynyl-2′-deoxyuridine (EdU), and colony-formation assays were employed to assess the impact of FAM50A on tumor cell proliferation. Flow cytometry was used to detect the changes of cell cycle. The cell cycle and cycle-related proteins were measured via western blotting (WB) to explore the potential mechanisms involving in cancer progresses.
Results
The results of IHC revealed a notable upregulation of FAM50A expression levels in CRC tissue compared with adjacent normal tissue. Moreover, FAM50A expression was positively correlated with N and TNM stages in 145 patients with CRC. Cox regression analysis and construction of a nomogram revealed that high FAM50A expression was a prognostic indicator for poor overall survival in patients with CRC. Knockdown of FAM50A decreased cell proliferation ability, the proportion of EdU positive cells, and the number of CRC cell colonies, whereas overexpressing FAM50A promoted proliferative phenotypes. Knocking down FAM50A induced a significant increase in the number of cells in the S phase. Meanwhile, CyclinA2 and CDK2 were significantly reduced after FAM50A knocking down.
Conclusion
FAM50A may be a novel prognostic marker for CRC, and may participate in regulating tumor progression by targeting the CyclinA2/CDK2 signal pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui, China.
- Department of Pharmacy, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
- Department of Gastrointestinal Surgery, Bozhou Hospital of Anhui Medical University, Bozhou, Anhui, China.
- Department of Internal Medicine Oncology, Jiangsu Cancer Hospital, Nanjing, Jiangsu, China.
ORCID-Profile: Longhai Li
Förderung
- Bozhou Key R&D projects
Zitieren
APA
Li, L., Ji, Z., Li, G., Gu, H., & Sun, Y. (2025). FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0318776
Vancouver
Li L, Ji Z, Li G, Gu H, Sun Y. FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0318776
BibTeX
@article{Li2025,
author = {Li, Longhai and Ji, Zhaoshuai and Li, Guangyun and Gu, Hao and Sun, Yan},
title = {FAM50A as a novel prognostic marker modulates the proliferation of colorectal cancer cells via CylinA2/CDK2 pathway},
journal = {PLOS ONE},
year = {2025},
doi = {10.1371/journal.pone.0318776}
}
EUVIMED